{"id":35954,"date":"2025-02-12T19:05:22","date_gmt":"2025-02-12T19:05:22","guid":{"rendered":"https:\/\/beyondtype1.org\/medicamentos-sglt-2-y-glp-1-como-ayudan-al-corazon\/"},"modified":"2025-02-12T19:10:29","modified_gmt":"2025-02-12T19:10:29","slug":"medicamentos-sglt2-glp1-corazon","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/","title":{"rendered":"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n"},"content":{"rendered":"<p style=\"text-align: center;\"><b><i>Nota del editor<\/i><\/b> <i><span style=\"font-weight: 400;\">: Los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 son medicamentos aprobados por la FDA para adultos con diabetes tipo 2 para ayudar a manejar los niveles de glucosa en sangre.<\/span><\/i><\/p>\n<p style=\"text-align: center;\"><i><span style=\"font-weight: 400;\">Habla siempre con tu m&eacute;dico antes de usar cualquier medicamento.<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">Si tienes diabetes y te preocupa la posibilidad de sufrir una enfermedad card&iacute;aca, hay buenas noticias.<\/span> <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2829848\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Una investigaci&oacute;n<\/span><\/a> <span style=\"font-weight: 400;\">reciente<\/span> de JAMA <span style=\"font-weight: 400;\">destaca c&oacute;mo<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/que-son-los-inhibidores-sglt-1-y-slgt-2-para-la-diabetes-tipo-1\/\"><span style=\"font-weight: 400;\">los inhibidores de SGLT2<\/span><\/a> <span style=\"font-weight: 400;\">y<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/todo-sobre-los-glp-1s\/\"><span style=\"font-weight: 400;\">los agonistas del receptor GLP-1<\/span><\/a> <span style=\"font-weight: 400;\">pueden ayudar a manejar los niveles de glucosa en sangre y mejorar<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/salud-del-corazon\/\"><span style=\"font-weight: 400;\">la salud card&iacute;aca<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span><\/p>\n<h3><b>Por qu&eacute; la salud card&iacute;aca es importante para la diabetes<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Las personas con diabetes<\/span> <a href=\"https:\/\/www.heart.org\/en\/health-topics\/diabetes\/diabetes-complications-and-risks\/cardiovascular-disease--diabetes\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">tienen m&aacute;s probabilidades de tener problemas card&iacute;acos<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<h3><b>Resultados del estudio sobre estos medicamentos<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los cient&iacute;ficos revisaron 601 estudios sobre estos medicamentos en adultos con diabetes tipo 2.<\/span><\/li>\n<\/ul>\n<h3><b>Adultos mayores<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los inhibidores de SGLT-2 redujeron menos el az&uacute;car en sangre, pero ayudaron a reducir los problemas card&iacute;acos.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los agonistas del receptor GLP-1 redujeron m&aacute;s el los niveles de glucosa en sangre, pero no ayudaron tanto con los problemas card&iacute;acos.<\/span><\/li>\n<\/ul>\n<h3><b>Hombres vs. mujeres<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">No se encontraron grandes diferencias entre hombres y mujeres que tomaban medicamentos SGLT-2 y GLP-1.<\/span><\/li>\n<\/ul>\n<h3><b>Posibles inconvenientes<\/b><\/h3>\n<p><span style=\"text-decoration: underline;\"><b>Inhibidores de SGLT-2<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Puede aumentar el riesgo de padecer<\/span> <a href=\"https:\/\/diabetesjournals.org\/care\/article\/42\/6\/991\/36067\/SGLT-Inhibitors-for-Type-1-Diabetes-Proceed-With\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">cetoacidosis diab&eacute;tica (CAD)<\/span><\/a> <span style=\"font-weight: 400;\">, una enfermedad grave.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Puede causar<\/span> <a href=\"https:\/\/diabetesjournals.org\/care\/article\/42\/6\/991\/36067\/SGLT-Inhibitors-for-Type-1-Diabetes-Proceed-With\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">infecciones genitales<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Puede provocar<\/span> <a href=\"https:\/\/diabetesjournals.org\/care\/article\/42\/6\/991\/36067\/SGLT-Inhibitors-for-Type-1-Diabetes-Proceed-With\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">deshidrataci&oacute;n<\/span><\/a> <span style=\"font-weight: 400;\">por micci&oacute;n frecuente.<\/span><\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\"><b>Agonistas del receptor GLP-1<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><a href=\"https:\/\/bmidoctors.com\/glp-1-agonists-vs-sglt2-inhibitors-an-in-depth-analysis-for-diabetes-patients\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Puede causar problemas estomacales<\/span><\/a> <span style=\"font-weight: 400;\">como n&aacute;useas y v&oacute;mitos.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">En raras ocasiones, puede<\/span> <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-investigating-reports-possible-increased-risk-pancreatitis-and-pre\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">causar pancreatitis<\/span><\/a> <i><span style=\"font-weight: 400;\">(p&aacute;ncreas inflamado<\/span><\/i> <span style=\"font-weight: 400;\">).<\/span><\/li>\n<\/ul>\n<h3><b>En resumen: beneficios y riesgos de SGLT-2 y GLP-1 <\/b><\/h3>\n<p><b><i>Beneficios:<\/i><\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ayuda a reducir los niveles de glucosa en la sangre.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los inhibidores de SGLT-2 pueden proteger su coraz&oacute;n y reducir el riesgo de problemas card&iacute;acos.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los agonistas del receptor GLP-1 pueden ayudar a perder peso.<\/span><\/li>\n<\/ul>\n<p><b><i>Riesgos:<\/i><\/b><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los inhibidores de SGLT-2 pueden causar deshidrataci&oacute;n, m&aacute;s infecciones y enfermedades raras pero graves como CAD.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los agonistas del receptor GLP-1 pueden causar n&aacute;useas, v&oacute;mitos o, raramente, pancreatitis.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: center;\"><em>La salud <span style=\"font-weight: 400;\">de tu<\/span> <a href=\"https:\/\/beyondtype1.org\/es\/salud-del-corazon\/\"><span style=\"font-weight: 400;\">coraz&oacute;n es importante<\/span><\/a> <span style=\"font-weight: 400;\">.<\/span> <\/em><\/p>\n<p style=\"text-align: center;\"><em>Trabaja con tu m&eacute;dico para encontrar el plan de atenci&oacute;n que se ajuste a sus necesidades espec&iacute;ficas.<\/em><\/p>\n<p style=\"text-align: center;\"><em>Mant&eacute;ngase siempre proactivo e informado sobre lo que es mejor para usted.<\/em><\/p>\n<p style=\"text-align: center;\">\n<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nota del editor : Los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 son medicamentos aprobados por la FDA para adultos con diabetes tipo 2 para ayudar a manejar los niveles de glucosa en sangre. Habla siempre con tu m&eacute;dico antes de usar cualquier medicamento. Si tienes diabetes y te preocupa la posibilidad de [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":35946,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-35954","resources","type-resources","status-publish","has-post-thumbnail","hentry","content-categories-noticias","topics-cuidado-de-la-salud","diabetes-types-tipo-2","tags-agonistas-del-receptor-glp-1","tags-diabetes-tipo-2","tags-inhibidores-de-sglt-2","tags-manejo-de-los-niveles-de-glucosa-en-sangre","tags-recurso","tags-salud-del-corazon"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-12T19:10:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1284\" \/>\n\t<meta property=\"og:image:height\" content=\"736\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/\",\"name\":\"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png\",\"datePublished\":\"2025-02-12T19:05:22+00:00\",\"dateModified\":\"2025-02-12T19:10:29+00:00\",\"description\":\"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png\",\"width\":1284,\"height\":736,\"caption\":\"SGLT-2 and GLP-1 Medicines: How They Help Your Heart\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1","description":"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/","og_locale":"es_ES","og_type":"article","og_title":"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1","og_description":"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.","og_url":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2025-02-12T19:10:29+00:00","og_image":[{"width":1284,"height":736,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/","url":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/","name":"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png","datePublished":"2025-02-12T19:05:22+00:00","dateModified":"2025-02-12T19:10:29+00:00","description":"Descubre c\u00f3mo los inhibidores de SGLT-2 y los agonistas del receptor GLP-1 mejoran la salud card\u00edaca y el manejo de la glucosa en sangre en personas con diabetes tipo 2.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/02\/Screenshot-2025-02-10-at-1.58.38-PM.png","width":1284,"height":736,"caption":"SGLT-2 and GLP-1 Medicines: How They Help Your Heart"},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/medicamentos-sglt2-glp1-corazon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Medicamentos SGLT-2 y GLP-1: c\u00f3mo ayudan al coraz\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/35954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=35954"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/35954\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/35946"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=35954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}